Campbell & CO Investment Adviser LLC Catalyst Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $253,082 - $328,546	19,202 New	19,202 $306,000
Q1 2023 May 11, 2023	SELL	$14.34 - $21.05 $404,215 - $593,357	-28,188 Reduced 47.05%	31,721 $525,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $154,999 - $246,733	-12,653 Reduced 17.44%	59,909 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $577,543 - $1.27 Million	-81,805 Reduced 52.99%	72,562 $931,000
Q2 2022 Aug 09, 2022	BUY	$6.23 - $8.57 $118,282 - $162,710	18,986 Added 14.02%	154,367 $1.08 Million
Q1 2022 May 09, 2022	BUY	$5.31 - $8.31 $314,251 - $491,794	59,181 Added 77.67%	135,381 $1.12 Million
Q4 2021 Feb 10, 2022	BUY	$5.21 - $7.45 $231,845 - $331,525	44,500 Added 140.38%	76,200 $516,000
Q3 2021 Nov 10, 2021	SELL	$4.85 - $6.04 $54,319 - $67,648	-11,200 Reduced 26.11%	31,700 $168,000
Q2 2021 Aug 11, 2021	BUY	$4.29 - $6.05 $184,041 - $259,545	42,900 New	42,900 $247,000

331

95.3M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.32B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.